|
|
Volumn 282, Issue 17, 1999, Pages 1668-1669
|
|
Exploring the benefits and limits of highly active antiretroviral therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
GAG PROTEIN;
VIRUS RNA;
CYTOMEGALOVIRUS INFECTION;
EDITORIAL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
LYMPHOCYTE COUNT;
PRIORITY JOURNAL;
RETINITIS;
VIRUS LOAD;
VIRUS REPLICATION;
|
|
EID: 0033520672
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.282.17.1668 Document Type: Editorial |
|
Times cited : (10)
|
|
References (27)
|
